VOR
Vor Biopharma Inc. · Healthcare
16.85
3.56%(+0.58)
Prev. Close19.00
12.76%(+2.15)
Pre-marketLast Updated: — ET
52W L: $2.6252W H: $65.80
$17.29
CHG+2.51 (+16.98%)
H$19.70
L$11.70
VOL15M
VOR (1h)
Vor Biopharma Inc. · Healthcare
RA CAPITAL MANAGEMENT, L.P.
director, 10 percent owner:
258,475 SH @ $18.23
2026-04-02
RA CAPITAL MANAGEMENT, L.P.
director, 10 percent owner:
1,525 SH @ $19.06
2026-04-02
RA CAPITAL MANAGEMENT, L.P.
director, 10 percent owner:
537,754 SH @ $16.51
2026-04-06
RA CAPITAL MANAGEMENT, L.P.
director, 10 percent owner:
44,728 SH @ $17.31
2026-04-06
RA CAPITAL MANAGEMENT, L.P.
director, 10 percent owner:
6,775 SH @ $18.50
2026-04-06
TCG Crossover GP II, LLC
10 percent owner
0 SH @ $0.00
2026-03-30
RA CAPITAL MANAGEMENT, L.P.
director, 10 percent owner:
4,625,346 SH @ $10.81
2025-12-18
RA CAPITAL MANAGEMENT, L.P.
director, 10 percent owner:
3,000 SH @ $12.80
2025-12-18
Shares of Vor Biopharma Inc. (NASDAQ: VOR - Get Free Report) have earned a consensus rating of "Moderate Buy" from the thirteen ratings firms that are covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating, six have given a buy rating and
